Open innovation: A Paradigm Shift in Pharma R&D?
The Science Direct website reported that Open innovation (OI) holds promise to accelerate, diversify, and innovate research and development (R&D) in the pharmaceutical industry. It remains to be assessed in which way and to what extent OI is leveraged in practice by current pharmaceutical R&D organizations. Therefore, here we comprehensively analyzed 21 research-based pharmaceutical companies and benchmarked their implementation of OI. Our data showed that OI is an integral part of R&D of all assessed pharmaceutical companies.
Click here to read the full abstract of the article.